How to Define Patients at High Risk for Pancreatic Cancer

被引:5
|
作者
Yamaguchi, Koji [1 ]
机构
[1] Univ Occupat & Environm Hlth Japan, Dept Surg 1, Sch Med, Yahatanishiku Ku, Kitakyushu 8078555, Japan
关键词
Diabetes mellitus; High-risk pancreatic cancer; Intraductal papillary mucinous neoplasm; Pancreatic cancer; DIABETES-MELLITUS; CIGARETTE-SMOKING; PHYSICAL-ACTIVITY; DUCTAL CARCINOMA; GLUCOSE; OBESITY; COHORT; COFFEE; EPIDEMIOLOGY; METAANALYSIS;
D O I
10.1159/000323477
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The clinical outcome of patients with pancreatic cancer remains dismal despite recent advances in diagnostic and therapeutic modalities. Several risk factors have been reported regarding the development of pancreatic cancer. These risk factors include family history, accompanying diseases, and lifestyle/personal habits. Family history includes that of pancreatic cancer and hereditary pancreatic cancer syndrome. Accompanying diseases that increase the risk include diabetes mellitus, obesity, chronic pancreatitis, hereditary pancreatic cancer syndrome and intraductal papillary mucinous neoplasms. Lifestyle-associated factors include smoking and diet. Detailed examination of patients with such risk factors is warranted, but the cost-benefit effect should be considered. Thus, patients with more than one risk factor should be carefully followed up, and periodic examination of such patients is necessary to ensure the detection of smaller and less-advanced pancreatic cancer lesions and thus to improve the clinical outcome of patients with pancreatic cancer. Copyright (C) 2011 S. Karger AG, Basel and IAP
引用
收藏
页码:3 / 6
页数:4
相关论文
共 50 条
  • [1] How should we define patients who are at high risk of death from prostate cancer?
    Vickers, Andrew
    NATURE CLINICAL PRACTICE UROLOGY, 2007, 4 (12): : 646 - 647
  • [2] How should we define patients who are at high risk of death from prostate cancer?
    Andrew Vickers
    Nature Clinical Practice Urology, 2007, 4 : 646 - 647
  • [3] How to Define and Manage Borderline Resectable Pancreatic Cancer
    Papavasiliou, Pavlos
    Chun, Yun Shin
    Hoffman, John P.
    SURGICAL CLINICS OF NORTH AMERICA, 2013, 93 (03) : 663 - +
  • [4] Pancreatic Cancer Pancreatic Cancer: Monitoring of High-risk Patients?
    Ruchalla, Elke
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2016, 54 (09): : 1043 - 1043
  • [5] Management of patients at high risk for pancreatic cancer
    Supot Pongprasobchai
    Suresh T. Chari
    Current Treatment Options in Gastroenterology, 2003, 6 (5) : 349 - 358
  • [6] How to define high risk BCC and SCC?
    Lear, J.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 : 23 - 23
  • [7] Incidence and risk of pancreatic cancer in patients with chronic pancreatitis: define optimal subgroup for surveillance
    Noh, Seunghwan
    Chang, Jae Hyuck
    CANCER RESEARCH, 2022, 82 (22) : 29 - 30
  • [8] Questioning How to Define the "Ultra-High-Risk" Subgroup of Neuroblastoma Patients
    Demir, A. B.
    Aktas, S.
    Altun, Z.
    Ercetin, P.
    Aktas, T. C.
    Olgun, N.
    FOLIA BIOLOGICA, 2021, 67 (01) : 1 - 15
  • [9] Hemorrhagic risk in patients candidates for coronary angioplasty: how to define, identify and treat high-risk patients
    Fimiani, Luigi
    Laterra, Giulia
    Caracciolo, Alessandro
    Cerrato, Enrico
    D'Ascenzo, Fabrizio
    Piccolo, Raffaele
    Capodanno, Davide
    Costa, Francesco
    GIORNALE ITALIANO DI CARDIOLOGIA, 2020, 21 (02) : 5S - 13S
  • [10] High-Risk Pancreatic Cancer Patients and Quality of Life
    Han, S.
    Kheder, J.
    Kaufman, D.
    Bocelli, L.
    Wachholtz, A.
    Wassef, W.
    PANCREAS, 2014, 43 (08) : 1363 - 1363